NEW YORK, June 8, 2026, 17:06 EDT
- UiPath shares were recently at $11.17, down about 0.7%, on volume of about 38.9 million shares.
- The move came after a strong fiscal first quarter but cautious analyst notes on recurring revenue growth.
- Investors are weighing UiPath’s AI automation pitch against larger workflow and software platforms.
UiPath’s U.S.-listed shares slipped late Monday, lagging a firmer technology tape as investors looked past the automation software company’s raised outlook and focused on whether AI-related demand can lift recurring revenue at a faster pace. The stock was recently at $11.17, down about 0.7%, after touching an intraday low of $10.91.
The move matters because UiPath has become a test case for smaller software companies trying to show that “agentic AI” — software that can act through steps with limited human direction — can become durable contract revenue, not just product demos. Invesco QQQ, a large technology ETF, rose about 1.6%, while SPY, the S&P 500 ETF, edged up about 0.2%.
UiPath reported fiscal first-quarter revenue of $418 million, up 17% from a year earlier, and annual recurring revenue, or ARR, of $1.901 billion, up 12%. ARR is a subscription measure of revenue expected from contracts over the next year.
The company also posted GAAP operating income of $28 million. GAAP means generally accepted accounting principles, the standard U.S. accounting rulebook. Chief Executive Daniel Dines said UiPath’s agentic products were moving “from pilot to production,” while Chief Operating and Financial Officer Ashim Gupta said the company reached “first quarter GAAP profitability” for the first time. UiPath, Inc.
Still, the bar is not low. Morgan Stanley analyst Sanjit Singh cut his price target on UiPath to $15 from $17 and kept an Equal Weight rating, saying a solid quarter and higher revenue and margin guidance were offset by modest ARR flow-through that left the forward setup in “show-me” territory. TipRanks
BofA took a similar wait-and-see line even as it raised its target to $13 from $12. The firm kept an Underperform rating and said it wanted more evidence of a sustainable ARR growth acceleration before becoming more positive.
For the second quarter, UiPath expects revenue of $395 million to $400 million and ARR of $1.929 billion to $1.934 billion as of July 31. For fiscal 2027, it lifted its revenue forecast to $1.776 billion to $1.781 billion from a prior range of $1.754 billion to $1.759 billion.
The competitive fight is also getting harder. ServiceNow sells AI agents that plug into enterprise workflows, while Microsoft has been pushing Copilot and agent tools across its business software estate; both touch the same corporate budgets UiPath is courting. ServiceNow shares rose about 1.6% Monday, while Microsoft fell about 1.2%.
UiPath also has a partnership angle with Microsoft, not just a rivalry. The company says its Azure-based platform can bring agentic automation across Microsoft environments, and a 2025 integration lets developers embed UiPath automations and AI agents into Microsoft Copilot Studio.
The downside case is plain. UiPath warned in its latest quarterly filing that macroeconomic swings, government efficiency initiatives, foreign exchange, reliance on cloud and large language model providers, and new disruptive technologies could affect results. If customers delay large automation projects or if bigger platforms bundle similar tools more cheaply, the recent margin progress may not be enough to re-rate the stock.
The next scheduled investor date is UiPath’s annual meeting on June 25. Until then, the shares may keep trading less on the headline beat and more on the harder question: whether AI agents can turn into faster ARR growth.
